Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
Group
Companies
History
Business model
Mission and vision
Corporate values
Commitment to sport
Research
Pharmaceutical Research
Sucrosomial Technology
Cetylated Fatty Acids
Quality and certifications
Brands
PharmaNutra
Junia Pharma
Alesco
Akern
Investor
INVESTOR RELATIONS
Stock performance
Share capital and Shareholders
Shares study and research
Broker
Financial statements
Presentations
Corporate events
Company presentation
Notice of meetings
SDIR
AIM admission document
MTA prospectus
PRESS
Press releases
Press review
Governance
Code of Ethics
231 Model
Board of Directors and Committees
Company documents
Internal dealing
Shareholders’ meeting
Statutory auditors and Audit firm
Sharholders Agreements
Sustainability
News
Science
Corporate
Events
Social commitment
Careers
Work with us
Job offers
Job application
it
en
17 March 2023
PROXY FORM EX ART 135 NOVIES
16 March 2023
2022 FY FINANCIAL RESULTS
21 February 2023
Investor Day February 2023
14 November 2022
INTERIM MANAGEMENT REPORT 30/09/2022
07 November 2022
2022 Q3 FINANCIAL RESULTS
14 September 2022
H1 FINANCIAL REPORT 30/06/2022
05 September 2022
2022 H1 FINANCIAL RESULTS
01 July 2022
ISMO CONFERENCE – PARIS
27 May 2022
NOTICE OF SHAREHOLDERS’ MEETING
12 May 2022
INTERIM MANAGEMENT REPORT 31/03/2022
10 May 2022
Q1 2022 FINANCIAL RESULTS
02 May 2022
SYNTHETIC REPORT ON VOTING RESULTS
<
1
…
4
5
6
…
16
>